Clarençon, Frédéric
Papagiannaki, Chrysanthi
Saleme, Suzanna
Rouchaud, Aymeric
Shotar, Eimad
Rius, Emily
Burel, Julien
Boch, Anne-Laure
Sourour, Nader-Antoine
Mounayer, Charbel
Article History
Received: 24 August 2022
Accepted: 16 May 2023
First Online: 4 July 2023
Declarations
:
: F. Clarençon is consultant for Medtronic, Balt Extrusion, Penumbra, Microvention and Stryker; board member of Artedrone and has stock options with Intradys. N.-A. Sourour is consultant for Medtronic, Balt Extrusion and Microvention. C. Papagiannaki is consultant for Microvention, Balt Extrusion and Stryker. A. Rouchaud is consultant for Balt Extrusion and Microvention. and C. Mounayer is consultant for Balt Extrusion and Microvention. S. Saleme, E. Shotar, E. Rius, J. Burel and A.-L. Boch declare that they have no competing interests.
: For this article no studies with animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.